Larvol Delta - Adrecizumab-an-investigational-agent-for-the-biomarkerguided-treatment-of-sepsis

adrecizumab (HAM 8101) - Adrenomed

http://www.ncbi.nlm.nih.gov/pubmed/33256482

Dec 3, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next